Objective: To prospectively examine whether men with restless legs syndrome (RLS) had an increased risk of mortality.Method: This was a prospective cohort study of 18,425 US men free of diabetes, arthritis, and renal failure in the Health Professionals Follow-up Study (HPFS). In 2002, RLS was assessed using a set of standardized questions. Deaths were identified from state vital statistics records, the National Death Index, family reports, and the postal system.Results: During 8 years of follow-up (2002-2010), we documented 2,765 deaths. In an age-adjusted model, RLS was associated with a 39% increased risk of mortality (hazard ratio [HR] 5 1.39; 95% confidence interval [CI] 1.19-1.62; p , 0.0001). The association between RLS and mortality was slightly attenuated after further adjustment for body mass index, lifestyle factors, chronic conditions, sleep duration, and other sleep-related disorders (adjusted HR 5 1.30; 95% CI 1.11-1.52; p 5 0.003). When we further excluded those with major chronic conditions (e.g., cancer, high blood pressure, cardiovascular disease, and other comorbidities), the adjusted HR was 1.92 (95% CI 1.03-3.56; p 5 0.04). The interactions between RLS and other risk factors (older age, overweight, short sleep duration, smoking, low physical activity, and unhealthy diet) in relation to total mortality risk were not significant (p for interaction .0.2 for all).
Conclusion:We observed that men with RLS had a higher overall mortality and this association was independent of known risk factors. The increased mortality in RLS was more frequently associated with respiratory disease, endocrine disease, nutritional/metabolic disease, and immunologic disorders. Future research exploring the pathophysiologic relationship between these disorders and RLS is warranted. Neurology Restless legs syndrome (RLS) is a bothersome chronic condition, characterized by an almost irresistible urge to move the legs and usually occurring with leg sensations of burning, creeping, tugging, or "like insects crawling inside the legs," which are worse in the evening and night with significant relief in the morning.1-3 This sensorimotor disorder was described in the late 17th century by Sir Thomas Willis and was coined RLS by Karl Ekbom in the 1940s.2 RLS affects 5%-10% of adults in the general population, 4-8 and is associated with various chronic conditions.
9A notable high mortality associated with RLS has been observed among men and women with renal disease. 10,11 In the general population, 3 previous studies 12-14 examined the association between RLS symptoms and mortality and reported inconsistent results. However, these studies are limited by small sample size, failure to employ standard questions to assess RLS, 12,13 or lack of information on RLS frequency.